$79.51
0.25% day before yesterday
Nasdaq, Dec 27, 10:09 pm CET
ISIN
US36266G1076
Symbol
GEHC
Sector

GE HealthCare Technologies Stock price

$79.51
-3.49 4.20% 1M
+0.69 0.88% 6M
+2.19 2.83% YTD
+1.84 2.37% 1Y
+19.51 32.52% 3Y
+19.51 32.52% 5Y
+19.51 32.52% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.20 0.25%
ISIN
US36266G1076
Symbol
GEHC
Sector

Key metrics

Market capitalization $36.33b
Enterprise Value $43.69b
P/E (TTM) P/E ratio 21.78
EV/FCF (TTM) EV/FCF 25.77
EV/Sales (TTM) EV/Sales 2.23
P/S ratio (TTM) P/S ratio 1.86
P/B ratio (TTM) P/B ratio 4.37
Dividend yield 0.15%
Last dividend (FY24) $0.12
Revenue growth (TTM) Revenue growth 1.42%
Revenue (TTM) Revenue $19.56b
EBIT (operating result TTM) EBIT $2.85b
Free Cash Flow (TTM) Free Cash Flow $1.70b
Cash position $3.57b
EPS (TTM) EPS $3.65
P/E forward 19.40
P/S forward 1.85
EV/Sales forward 2.22
Short interest 2.42%
Show more

Create a Free Account to create an GE HealthCare Technologies alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

GE HealthCare Technologies Stock Analysis

Analyst Opinions

20 Analysts have issued a GE HealthCare Technologies forecast:

12x Buy
60%
7x Hold
35%
1x Sell
5%

Analyst Opinions

20 Analysts have issued a GE HealthCare Technologies forecast:

Buy
60%
Hold
35%
Sell
5%

Financial data from GE HealthCare Technologies

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
19,558 19,558
1% 1%
100%
- Direct Costs 11,458 11,458
2% 2%
59%
8,100 8,100
7% 7%
41%
- Selling and Administrative Expenses 3,386 3,386
0% 0%
17%
- Research and Development Expense 1,282 1,282
10% 10%
7%
3,432 3,432
12% 12%
18%
- Depreciation and Amortization 585 585
6% 6%
3%
EBIT (Operating Income) EBIT 2,847 2,847
17% 17%
15%
Net Profit 1,676 1,676
3% 3%
9%

In millions USD.

Don't miss a Thing! We will send you all news about GE HealthCare Technologies directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

GE HealthCare Technologies Stock News

Positive
Seeking Alpha
10 days ago
GE HealthCare shares have surged nearly 27% since October 2023, driven by AI-driven strategies and innovation in healthcare diagnostics, despite some volatility in revenue growth. The bullish outlook for 2025 is supported by GEHC's AI advancements, expected sales and profitability improvements, and a significant backlog of $19.6 billion. AI-driven healthcare solutions are projected to enhance d...
Neutral
Business Wire
17 days ago
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its fourth quarter and full year 2024 financial results before the market opens on Thursday, February 13, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehe...
Positive
Seeking Alpha
22 days ago
GE HealthCare Technologies is rated a buy due to strong growth prospects, a healthy backlog, and favorable valuation compared to peers. The company's revenue growth is supported by new product innovations, including the FDA-approved Flyrcado, and potential recovery in Chinese demand. Margins are expected to improve through cost optimization, volume leverage, and strategic pricing, with a medium...
More GE HealthCare Technologies News

Company Profile

GE Healthcare Technologies, Inc. operates as a holding company with interest in providing medical technology, pharmaceutical diagnostics and digital solutions. Its operating segments include Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded on May 16, 2022 and is headquartered in Chicago, IL.

Head office United States
CEO Peter Arduini
Employees 51,000
Founded 2022
Website www.gehealthcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today